Sangamo BioSciences (SGMO) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Sangamo Therapeutics (SGMO) kompaniyasining ushbu kunlik narxlar grafigi genom tahrirlash va molekulyar tibbiyot sohasidagi fundamental yutuqlarga intilayotgan vizionerlar tomonidan boshqarilayotgan kompaniya dinamikasini aks ettiradi. Biznes sanoat gigantlari bilan hamkorlikka asoslangan, ammo klinik sinovlarning sur'ati FDA ning qat'iy tartibga soluvchi qoidalari bilan cheklangan. Operatsion tamoyillar bioetik shaffoflik va barqaror chiqindilarni yo'q qilishni o'z ichiga oladi, va ko'rsatkich 0.00 darajasida turibdi.
Sangamo Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Sangamo Therapeutics|SGMO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi sangamo.com|SGMO - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Sangamo Therapeutics, Inc.|SGMO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Sangamo Therapeutics|Tezkor likvidlik ko‘rsatkichi sangamo.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:SGMO - Sangamo Therapeutics Inc.
Yuqori xavfli gen tahrirlash sektorida faoliyat yurituvchi Sangamo Therapeutics (SGMO) uchun uzoq muddatli qarzdorlikning kapitalga nisbati potensial sherikliklarning buzilishi sharoitida uning moliyalashtirish tuzilmasining barqarorligini aks ettiradi. Ushbu grafik uzoq muddatli majburiyatlarning aksiyadorlar kapitaliga nisbatini o'lchaydi, bu esa investorlarga leveraj darajasini va kompaniyaning aktivlarga jiddiy bosim o'tkazmasdan uzoq muddatli tadqiqot xarajatlarini qoplash qobiliyatini baholash imkonini beradi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati GeneDx Holdings WGS|RARE: Uzoq muddatli qarzning kapitalga nisbati|Beam Tx (BEAM) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TWST (twistbioscience.com)|Uzoq muddatli qarzning kapitalga nisbati TXG|Intellia Therapeutics Inc (NTLA) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati STOK (Stoke)|Uzoq muddatli qarzning kapitalga nisbati BioLife BLFS|WVE - Uzoq muddatli qarzning o'z kapitaliga nisbati|mazetx.com (MAZE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Sionna Therapeutics (SION) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Prime Medicine Inc (PRME)|Uzoq muddatli qarzning o'z kapitaliga nisbati TSHA|QURE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati MGTX (MeiraGTx Holdings plc)|Uzoq muddatli kreditlarning kapitalga nisbati RGNX|Uzoq muddatli qarzning kapitalga nisbati SLDB (Solid Biosciences)|Uzoq muddatli qarzning kapitalga koeffitsiyenti OCGN|Pacific Biosciences of California - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Benitec Corp|Design Therapeutics (DSGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|rocketpharma.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|FDMT (4D Molecular Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Lexeo|Uzoq muddatli qarzning o'z kapitaliga nisbati Korro Bio, Inc. (KRRO)|EDIT: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SLN (Silence Therapeutics)|ProQR (PRQR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CDXS: Uzoq muddatli qarzning o'z kapitaliga nisbati|NAUT - Uzoq muddatli qarzning kapitalga nisbati|MGX (Metagenomi, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|DTIL: Uzoq muddatli kreditlarning kapitalga nisbati|GBIO (Generation Bio Co) - Uzoq muddatli qarzning kapitalga nisbati|boundlessbio.com (BOLD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati XCUR|Uzoq muddatli qarzning o'z kapitaliga nisbati imunon.com IMNN|Uzoq muddatli qarzning o'z kapitaliga nisbati Phio Pharmaceuticals Corp. PHIO|Uzoq muddatli qarzdorlikning kapitalga nisbati Mustang Bio Inc (MBIO)|RNAZ - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Bionano Genomics, Inc. BNGO|APDN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati bluebird bio Inc. BLUE|Uzoq muddatli qarzning o'z kapitaliga nisbati ImmunoPrecise Antibodies Ltd|Uzoq muddatli qarzning o'z kapitaliga nisbati Omega Therapeutics Corp (OMGA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|RGLS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|TBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|UBX (Unity Biotechnology, Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi